Study of the Efficacy and Safety for Rituximab in Myalgia Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)
Clinical trial NCT06952413 · RECRUITING
Trial details
- NCT number
- NCT06952413
- Sponsor
- National Center of Neurology and Psychiatry, Japan
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-04-09
- Primary completion
- 2026-09-30
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.